Skip to main content
NIH funding notice PAR-14-348

Planning Grants for Clinical Trials of High Relevance to the NIGMS Mission (R34)

Closed on November 14, 2016.

Posted
September 25, 2014
Close date
November 14, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $158,389 in first-year total cost, median $158,389.

Most frequent study sections

  1. Special Emphasis Panel[ZGM1 PPBC-5 (CL)]1

Most frequent institutions

  1. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
Competing awards under PAR-14-348 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Immunotherapy of sepsis using anti-PDL1 antibody1R34GM107650-01A1ANGUS, DEREK CHOTCHKISS, RICHARD SAMUELYENDE, SACHINUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$158,389ZGM1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.